Low Testosterone in Women: Symptoms, Causes, and Treatment Options in Orlando

You Are Not Crazy. Your Symptoms Deserve Investigation.

How many times have you been told your fatigue is just “part of being a busy mom”? That your brain fog will pass? That your lack of interest in sex is normal after 40?

Many women in perimenopause and menopause experience overlapping symptoms that feel difficult to explain: changes in mood, energy, sleep, and interest in intimacy. These symptoms can resemble depression, anxiety, or thyroid disease. Yet for a significant proportion of women, hormone change is playing a meaningful role that deserves clinical attention.

Here is what many doctors don’t explore thoroughly enough: testing hormones should be part of a broader evaluation, alongside assessment of thyroid function, sleep quality, medications, mood history, and life stressors. When this thorough approach is missing, real causes go unaddressed.

This guide explains what we know – and what we still don’t – about testosterone’s role in women’s health, how to get properly evaluated, and what options exist if hormone optimization is appropriate for you.

The Diagnostic Gap: Why Symptoms Often Get Misnamed

The evidence on misdiagnosis during perimenopause is substantial. A 2025 survey of over 1,000 American women found that 39% of perimenopausal women reported misdiagnosis, with clinicians treating anxiety and depression without investigating the hormonal context.

However, this does not mean depression is imaginary or that every woman with low mood has a hormone problem. Perimenopause and depression symptoms overlap significantly. Seven of the eight diagnostic criteria for depression on standardized screening tools – sleep disruption, appetite changes, fatigue, difficulty concentrating, and mood disturbance – can be caused by hormonal change, thyroid dysfunction, sleep apnea, or medication side effects.

This diagnostic overlap requires careful clinical evaluation, not assumptions. Women are 1.5 to 2 times more likely to experience depressive symptoms during perimenopause compared to earlier life stages.

The Triangle of Hormones: Testosterone’s Actual Role in Women

Hormone balance involves three primary hormones that work together and decline during perimenopause and menopause: estrogen, progesterone, and testosterone. Understanding testosterone’s physiology helps clarify why it matters.

Testosterone in Women: Basic Physiology

Before menopause, women produce testosterone continuously, though at lower absolute levels than men. Testosterone is produced by the ovaries and adrenal glands. It plays measurable roles in bone metabolism, sexual function, and brain chemistry. During perimenopause, ovarian testosterone production declines alongside estrogen and progesterone.

Where the Evidence Is Strongest: Sexual Desire

The clearest, most well-supported clinical indication for testosterone therapy in women is the treatment of Hypoactive Sexual Desire Disorder (HSDD) in postmenopausal women. HSDD is not low libido caused by relationship problems, stress, or medications – it is a clinical condition characterized by persistent, distressing absence of sexual thoughts, fantasies, or desire.

Evidence from the International Society for the Study of Women’s Sexual Health (ISSWSH, 2021) and the Global Consensus Position Statement (endorsed by the Endocrine Society, Menopause Society, and other major organizations) concludes: testosterone therapy can improve sexual desire and satisfaction in carefully selected postmenopausal women with HSDD. This is the one indication with robust supporting evidence.

Where the Evidence Is Limited: Bone Density, Mood, and Cognition

While some observational studies suggest associations between testosterone levels and bone density, and isolated studies have examined cognition, the VA Clinical Summary (2025) and ISSWSH guidelines explicitly state: testosterone therapy is not recommended off-label for improvement in bone mineral density, mood, or cognitive function in women, due to lack of evidence of benefit.

This is an important distinction. Observational studies showing associations between testosterone levels and health outcomes do not prove that giving testosterone to women with low levels will produce those benefits. The randomized controlled trial evidence for these uses is absent.

Symptoms That Warrant Evaluation: But Not Diagnosis by Checklist

If you experience any of the following, a thorough health evaluation is warranted. This evaluation should include hormone testing, but also thyroid testing, sleep assessment, mood screening, and medication review:

The Regulatory Reality: Understanding Off-Label Use

Before discussing treatment options, transparency is essential: there are no FDA-approved testosterone products for women in the United States. The FDA declined to approve testosterone for women in 2004 due to insufficient long-term safety data.

This means any testosterone therapy prescribed to women is off-label use. Off-label prescribing is legal and common in medicine, but it carries important implications: the prescribing clinician has additional responsibility for careful patient selection, informed consent, appropriate dosing, and regular monitoring.

At APMUC, if hormone therapy is recommended, you will receive a detailed conversation about:

• What the evidence does and does not support
• The specific indication (e.g., HSDD) for which you are being treated
• Potential risks and benefits based on your individual health profile
• How therapy will be monitored
• Your right to decline or discontinue at any time

Appropriate Evaluation Before Hormone Therapy

If evaluation suggests HSDD or another indication for which hormone testing is relevant, here is what proper assessment includes:

Who Should Not Use Testosterone Therapy

Addressing Common Fears: Virilization and Masculinization

One legitimate concern women voice is fear of masculinization: deepening voice, facial hair growth, clitoral enlargement, or other androgen effects.

The key distinction is between physiologic and supraphysiologic dosing. These effects occur with supraphysiologic doses – doses far above what the female body naturally produces. Bodybuilders using testosterone at many times the normal female range will experience these changes. This is not the goal of clinical hormone optimization.

Physiologic testosterone therapy aims to restore hormone levels to the normal premenopausal female range, approximately 15-70 ng/dL. At physiologic doses, as documented in clinical studies, virilization effects are not expected.

If testosterone is recommended, your clinician will use precise dosing and regular monitoring to ensure levels remain in the physiologic range. This is non-negotiable.

Bioidentical Hormone Optimization: How It Works

If evaluation concludes that hormone therapy is appropriate, here is what the process typically involves:

The Evidence on Safety

Hormone therapy for postmenopausal women, including testosterone, has both benefits and risks that require careful consideration. Here is what current evidence indicates:

Short-Term Efficacy and Safety: Transdermal testosterone at physiologic doses has been shown safe and effective in randomized controlled trials for HSDD, with primary side effects being mild skin irritation and occasional mood changes.

Long-Term Safety: Long-term safety data in women is limited compared to men, largely because testosterone use in women is relatively recent. This is one reason the FDA has not approved testosterone for women. Ongoing monitoring during therapy is essential.

Pellet-Specific Considerations: If testosterone is delivered via subcutaneous pellet, important points include:

• Pellets cannot be removed if problems develop (unlike patches or gels)
• Peak hormone levels may be higher with pellets than with transdermal therapy
• Complication rates (extrusion, infection) are low when inserted by trained providers
• Regular blood work is essential to verify hormone levels remain physiologic

Cardiovascular and Breast Cancer Risk: Some observational studies have suggested associations between hormone use and cardiovascular or breast cancer risk. However, these associations are inconsistent, and randomized controlled trial evidence is lacking. This remains an area of uncertainty, which is why careful patient selection and informed consent are critical.

When to Seek Immediate Care

The Larger Truth: You Deserve Thorough Care

This guide exists because one central truth persists in women’s healthcare: symptoms get pathologized instead of systematically investigated.

Low mood gets labeled depression without checking thyroid function. Fatigue gets attributed to stress without evaluating sleep. Sexual dysfunction gets dismissed as “normal aging” without exploring hormonal, vascular, or relationship factors.

At the same time, not every woman’s fatigue is hormonal, and not every mood change is rooted in hormone deficiency.

The answer is not hormones alone. It is thorough, systematic evaluation that considers thyroid function, sleep quality, medication effects, mood history, cardiovascular health, and hormone status.

You know your body. If something has changed, if you don’t feel like yourself, if previous evaluations have been incomplete, you deserve a second opinion. You deserve thorough testing. You deserve clarity about what may be contributing and what treatment options are appropriate for your situation.

That is what APMUC exists to provide.

Frequently Asked Questions